Literature DB >> 10232791

Seizure resistance is dependent upon age and calorie restriction in rats fed a ketogenic diet.

K J Bough1, R Valiyil, F T Han, D A Eagles.   

Abstract

The present study was designed to evaluate the effects of age on the efficacy of the ketogenic diet in suppressing seizures evoked by tail-vein infusion of pentylenetetrazole (PTZ). Male rats of various ages were divided into three groups and fed one of three diets: (1) a calorie-restricted ketogenic diet, (2) a calorie-restricted normal (rodent chow) diet, or (3) a normal diet, ad libitum. After animals had been on experimental or control diets for more than 20 days, seizure threshold and blood levels of beta-hydroxybutyrate (beta-OHB) were determined. Animals fed a ketogenic diet exhibited significant elevations in levels of beta-OHB and seizure resistance compared to animals fed either a calorie-restricted normal diet or a normal diet, ad libitum. The levels of beta-OHB and seizure resistance were greatest for young pups. A surprising finding was that young animals fed a calorie-restricted rodent chow diet exhibited a significantly increased resistance to seizures compared to those fed the same diet, ad libitum. Results presented here demonstrate that the ketogenic diet produces the highest levels of ketonemia and seizure threshold in young animals. Collectively, these data suggest that age and caloric restriction are important considerations for implementing the ketogenic diet.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10232791     DOI: 10.1016/s0920-1211(98)00125-9

Source DB:  PubMed          Journal:  Epilepsy Res        ISSN: 0920-1211            Impact factor:   3.045


  40 in total

1.  Intermittent fasting dissociates beneficial effects of dietary restriction on glucose metabolism and neuronal resistance to injury from calorie intake.

Authors:  R Michael Anson; Zhihong Guo; Rafael de Cabo; Titilola Iyun; Michelle Rios; Adrienne Hagepanos; Donald K Ingram; Mark A Lane; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-30       Impact factor: 11.205

Review 2.  Caloric restriction and intermittent fasting: two potential diets for successful brain aging.

Authors:  Bronwen Martin; Mark P Mattson; Stuart Maudsley
Journal:  Ageing Res Rev       Date:  2006-08-08       Impact factor: 10.895

3.  Energy balance and hypothalamic effects of a high-protein/low-carbohydrate diet.

Authors:  Kimberly P Kinzig; Sara L Hargrave; Jayson Hyun; Timothy H Moran
Journal:  Physiol Behav       Date:  2007-04-22

Review 4.  Cerebral metabolic adaptation and ketone metabolism after brain injury.

Authors:  Mayumi L Prins
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-08       Impact factor: 6.200

5.  Seizure tests distinguish intermittent fasting from the ketogenic diet.

Authors:  Adam L Hartman; Xiangrong Zheng; Emily Bergbower; Michiko Kennedy; J Marie Hardwick
Journal:  Epilepsia       Date:  2010-04-30       Impact factor: 5.864

Review 6.  Ketogenic diets, mitochondria, and neurological diseases.

Authors:  Lindsey B Gano; Manisha Patel; Jong M Rho
Journal:  J Lipid Res       Date:  2014-05-20       Impact factor: 5.922

7.  Metformin Plus Caloric Restriction Show Anti-epileptic Effects Mediated by mTOR Pathway Inhibition.

Authors:  María Del Carmen Rubio Osornio; Verónica Custodio Ramírez; Daniela Calderón Gámez; Carlos Paz Tres; Karla G Carvajal Aguilera; Bryan V Phillips Farfán
Journal:  Cell Mol Neurobiol       Date:  2018-08-21       Impact factor: 5.046

8.  Comparison of Intermittent Fasting Versus Caloric Restriction in Obese Subjects: A Two Year Follow-Up.

Authors:  F B Aksungar; M Sarıkaya; A Coskun; M Serteser; I Unsal
Journal:  J Nutr Health Aging       Date:  2017       Impact factor: 4.075

9.  How does the ketogenic diet work? Four potential mechanisms.

Authors:  Nika N Danial; Adam L Hartman; Carl E Stafstrom; Liu Lin Thio
Journal:  J Child Neurol       Date:  2013-05-13       Impact factor: 1.987

10.  Reduced pain and inflammation in juvenile and adult rats fed a ketogenic diet.

Authors:  David N Ruskin; Masahito Kawamura; Susan A Masino
Journal:  PLoS One       Date:  2009-12-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.